BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Cell and Gene Therapy Sector’s Foremost Annual Conference
Oct 6, 2020
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced that it will present at the Alliance for Regenerative Medicine’s (“ARM”) virtual Cell and Gene Meeting on the Mesa, which is set to take place October 12-16, 2020. Genprex’s executive vice president and COO Michael Redman will lead the company’s presentation. The 2020 event will be delivered in a virtual format over the course of five days and feature on-demand company presentations and live-streaming panels. The Cell and Gene Meeting on the Mesa is the sector’s foremost annual conference, bringing together senior executives and top industry decision makers to advance cutting-edge research into cures. Tackling commercialization hurdles currently facing the cell and gene therapy sector, the conference covers a wide range of topics from clinical trial design to alternative, scalable payment models and supply chain platforms for advanced therapies. Interested parties should visit https://ibn.fm/ruXcY for more information or to register for the event.
To view the full press release, visit https://ibn.fm/kX4bh
About Genprex Inc.
Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “GPX-001” (“quaratusugene ozeplasmid”), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s “Tagrisso(R)”) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information about the company, visit www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Mona Agarwal doubles gold tally with world-record show at Asian Para Games
Mona Agarwal doubles gold tally with world-record show at Asian Para Games
Ishan Kishan out of 2nd T20I, Sooryavanshi will replace batter: Sitanshu Kotak
Ishan Kishan out of 2nd T20I, Sooryavanshi will replace batter: Sitanshu Kotak
Honduras squeezes Chinese firms; Super Typhoon Champi nears Taiwan: SCMP’s 7 highlights
We have selected seven stories from this week’s news across Hong Kong, mainland China, the wider Asia region and beyond that resonated with our readers and shed light on topical issues. If you would like to see more of our reporting, please consider subscribing. 1. Honduras targets Chinese shops, state builder as president sits on Taiwan pledge Honduran migration officials have summoned or placed under review 41 Chinese nationals after inspecting shops in the capital and a hospital being built...
Asian Para Games 2026: Haney Wins Javelin Throw Gold With World Record
Haney won gold with a world record javelin throw of 60.49m at the Asian Para Games 2026.
Para Asiad: Naveen Sivakumar Wins Badminton Gold, Thulasimathi And Nitya Take silver
India's Naveen Sivakumar won gold in the men's singles SL4 at the Asian Para Games 2026 in Nagoya, defeating Indonesia's Fredy Setiawan.
What do the protests in France look like from China? Internet users weigh in
Internet users in China are watching the protests in France with a mix of geopolitical cynicism, domestic pride and sadness at the damage to French landmarks. The protests started in September, when students and teachers in southeastern Paris rallied against deteriorating school conditions. Those specific grievances quickly escalated into nationwide protests at the rising cost of living and declining public services. What began as peaceful marches has since dissolved into violence, with rioters...
Asian Para Games: Sandeep Wins Men's 400m T64 Gold With New World Record, Ajay Kumar Takes Bronze
India's Sandeep won gold with a world record in the men's 400m T64 at the Asian Para Games in Nagoya.
Asian Para Games: Sandeep, Haney's world record gold take India past 100 medals
Asian Para Games: Sandeep, Haney's world record gold take India past 100 medals
Chinese state media takes aim at Japanese firm KDDI over Mongolia wildfire
Chinese state media has called for a Japanese telecoms firm to apologise to China over a huge wildfire in neighbouring Mongolia, as diplomatic tensions run high between Beijing and Tokyo. The grassland fire broke out on October 8 and burned about 80 per cent of a nature reserve on the Mongolia-China border. According to Japanese media reports, the company, KDDI, has acknowledged that the fire was linked to activities involving its majority-owned subsidiary MobiCom – the largest mobile network...
Asian Para Games: Nitesh Kumar Beats Compatriot Pramod Bhagat To Win Badminton Gold, Thulasimathi Murugesan Pockets Silver
India's Nitesh Kumar won the men's singles SL3 gold medal by defeating Pramod Bhagat at the Asian Para Games.
China’s Xi Jinping orders urgent relief after Tibet earthquake leaves 16 dead
All efforts need to be focused on search and rescue for survivors and treating the injured, President Xi Jinping instructed on Friday morning, after a 7.0-magnitude earthquake killed 16 and injured 65 in China’s Tibet autonomous region overnight. “The disaster-hit area is located in a high-altitude region with cold weather. It is imperative to closely monitor seismic activities and weather changes and implement rescue operations accordingly, while preventing secondary disasters,” he said,...
Anahat Singh scripts comeback to reach maiden PSA Gold semi-final
Anahat Singh scripts comeback to reach maiden PSA Gold semi-final
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.